Hyoscyamine Alternatives Compared
Hyoscyamine | Remicade | Stelara |
|
---|
Hyoscyamine | Remicade (infliximab) | Stelara (ustekinumab) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Hyoscyamine may be used in the treatment of a wide variety of gastrointestinal problems including cramps, bladder control issues, and irritable bowel syndrome. Drowsiness and dry mouth are common... View more |
Prescription only
Prescribed for Ankylosing Spondylitis, Crohn's Disease, Crohn's Disease - Active, Inflammatory Bowel Disease, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative... View more |
Prescription only
Stelara is an immunosuppressant medication that works by binding to two inflammatory cytokines, IL-12 and IL-23, which have been identified as important contributors to chronic inflammation. Stelara... View more |
Related suggestions Crohn's Disease
|
|||||||||||||||||||||||
More about Hyoscyamine | More about Remicade (infliximab) | More about Stelara (ustekinumab) | ||||||||||||||||||||||||
Generic Status | ||||||||||||||||||||||||||
No lower-cost generic available |
||||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Hyoscyamine has an average rating of 7.8 out of 10 from a total of 111 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 16% reported a negative effect. |
Remicade has an average rating of 7.1 out of 10 from a total of 204 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 20% reported a negative effect. |
Stelara has an average rating of 7.5 out of 10 from a total of 242 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: hyoscyamine side effects in more detail. |
See also: Remicade side effects in more detail. |
See also: Stelara side effects in more detail. |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all hyoscyamine prices |
View all Remicade prices and generic prices |
View all Stelara prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Anaspaz, Ed-Spaz, Hyosyne, Levbid, Levsin, Levsin SL, NuLev, Oscimin, Symax Duotab, Symax SL, Symax SR View more | Other infliximab brands include: Avsola, Inflectra, Ixifi, Renflexis, Zymfentra | Other ustekinumab brands include: Wezlana | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
4 hours |
228 hours |
1291.2 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 205 drugs are known to interact with hyoscyamine:
|
A total of 496 drugs are known to interact with Remicade:
|
A total of 455 drugs are known to interact with Stelara:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
August 24, 1998 |
September 25, 2009 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.